Journal of Peking University(Health Sciences) >
宁 张 , 慧 杨 , 鹏 王 . [J]. Journal of Peking University(Health Sciences), 2022 , 54(5) : 814 -821 . DOI: 10.19723/j.issn.1671-167X.2022.05.006
| 1 | Wu C , Li M , Meng H , et al. Analysis of status and countermeasures of cancer incidence and mortality in China[J]. Sci China Life Sci, 2019, 62 (5): 640- 647. |
| 2 | Li L , Knutsdottir H , Hui K , et al. Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity[J]. JCI Insight, 2019, 4 (2): e121490. |
| 3 | Gillet JP , Varma S , Gottesman MM . The clinical relevance of cancer cell lines[J]. J Natl Cancer Inst, 2013, 105 (7): 452- 458. |
| 4 | Byrne AT , Alferez DG , Amant F , et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts[J]. Nat Rev Cancer, 2017, 17 (4): 254- 268. |
| 5 | Gao H , Korn JM , Ferretti S , et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response[J]. Nat Med, 2015, 21 (11): 1318- 1325. |
| 6 | Sato T , Vries RG , Snippert HJ , et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459 (7244): 262- 265. |
| 7 | Jacob F , Salinas RD , Zhang DY , et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity[J]. Cell, 2020, 180 (1): 188- 204. |
| 8 | Fujii M , Shimokawa M , Date S , et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis[J]. Cell Stem Cell, 2016, 18 (6): 827- 838. |
| 9 | Rosenbluth JM , Schackmann RCJ , Gray GK , et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages[J]. Nat Commun, 2020, 11 (1): 1711. |
| 10 | Sato T , Stange DE , Ferrante M , et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium[J]. Gastroenterology, 2011, 141 (5): 1762- 1772. |
| 11 | Huch M , Dorrell C , Boj SF , et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration[J]. Nature, 2013, 494 (7436): 247- 250. |
| 12 | Schwarz JS , de Jonge HR , Forrest JN . Value of organoids from comparative epithelia models[J]. Yale J Biol Med, 2015, 88 (4): 367- 374. |
| 13 | Huch M , Gehart H , van Boxtel R , et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell, 2015, 160 (1/2): 299- 312. |
| 14 | Bartfeld S , Bayram T , van de Wetering M , et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection[J]. Gastroenterology, 2015, 148 (1): 126- 136. |
| 15 | Sachs N , de Ligt J , Kopper O , et al. A living biobank of breast cancer organoids captures disease heterogeneity[J]. Cell, 2018, 172 (1/2): 373- 386. |
| 16 | Hostiuc S , Rusu MC , Negoi I , et al. The moral status of cerebral organoids[J]. Regen Ther, 2019, 10, 118- 122. |
| 17 | Drost J , Clevers H . Organoids in cancer research[J]. Nat Rev Cancer, 2018, 18 (7): 407- 418. |
| 18 | Broutier L , Andersson-Rolf A , Hindley CJ , et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation[J]. Nat Protoc, 2016, 11 (9): 1724- 1743. |
| 19 | Fong ELS , Toh TB , Lin QXX , et al. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer[J]. Biomaterials, 2018, 159, 229- 240. |
| 20 | Tamai M , Adachi E , Tagawa Y . Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils[J]. Tissue Eng Part A, 2013, 19 (21/22): 2527- 2535. |
| 21 | Robertson MJ , Soibam B , O'Leary JG , et al. Recellularization of rat liver: an in vitro model for assessing human drug metabolism and liver biology[J]. PLoS One, 2018, 13 (1): e0191892. |
| 22 | Neal JT , Li X , Zhu J , et al. Organoid modeling of the tumor immune microenvironment[J]. Cell, 2018, 175 (7): 1972- 1988. |
| 23 | Deng J , Wang ES , Jenkins RW , et al. CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation[J]. Cancer Discov, 2018, 8 (2): 216- 233. |
| 24 | Dijkstra KK , Cattaneo CM , Weeber F , et al. Generation of tumor-reactive T Cells by co-culture of peripheral blood lymphocytes and tumor organoids[J]. Cell, 2018, 174 (6): 1586- 1598. |
| 25 | Gao D , Vela I , Sboner A , et al. Organoid cultures derived from patients with advanced prostate cancer[J]. Cell, 2014, 159 (1): 176- 187. |
| 26 | Barker N , Ridgway RA , van Es JH , et al. Crypt stem cells as the cells-of-origin of intestinal cancer[J]. Nature, 2009, 457 (7229): 608- 611. |
| 27 | van de Wetering M , Francies HE , Francis JM , et al. Prospective derivation of a living organoid biobank of colorectal cancer patients[J]. Cell, 2015, 161 (4): 933- 945. |
| 28 | Yan HHN , Siu HC , Law S , et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening[J]. Cell Stem Cell, 2018, 23 (6): 882- 897. |
| 29 | Vlachogiannis G , Hedayat S , Vatsiou A , et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science, 2018, 359 (6378): 920- 926. |
| 30 | Lee SH , Hu W , Matulay JT , et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer[J]. Cell, 2018, 173 (2): 515- 528. |
| 31 | Boj SF , Hwang CI , Baker LA , et al. Organoid models of human and mouse ductal pancreatic cancer[J]. Cell, 2015, 160 (1/2): 324- 338. |
| 32 | Seino T , Kawasaki S , Shimokawa M , et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression[J]. Cell Stem Cell, 2018, 22 (3): 454- 467. |
| 33 | Kopper O , de Witte CJ , Lohmussaar K , et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity[J]. Nat Med, 2019, 25 (5): 838- 849. |
| 34 | Lapointe S , Perry A , Butowski NA . Primary brain tumours in adults[J]. Lancet, 2018, 392 (10145): 432- 446. |
| 35 | Broutier L , Mastrogiovanni G , Verstegen MM , et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening[J]. Nat Med, 2017, 23 (12): 1424- 1435. |
| 36 | Nuciforo S , Fofana I , Matter MS , et al. Organoid models of human liver cancers derived from tumor needle biopsies[J]. Cell Rep, 2018, 24 (5): 1363- 1376. |
| 37 | Zhao Y , Li ZX , Zhu YJ , et al. Single-cell transcriptome analysis uncovers intratumoral heterogeneity and underlying mechanisms for drug resistance in hepatobiliary tumor organoids[J]. Adv Sci (Weinh), 2021, 8 (11): e2003897. |
| 38 | Yuan B , Zhao X , Wang X , et al. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening[J]. Clin Transl Med, 2022, 12 (1): e678. |
| 39 | Huang L , Holtzinger A , Jagan I , et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell and patient-derived tumor organoids[J]. Nat Med, 2015, 21 (11): 1364- 1371. |
| 40 | Matano M , Date S , Shimokawa M , et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids[J]. Nat Med, 2015, 21 (3): 256- 262. |
| 41 | Drost J , van Jaarsveld RH , Ponsioen B , et al. Sequential cancer mutations in cultured human intestinal stem cells[J]. Nature, 2015, 521 (7550): 43- 47. |
| 42 | Sun L , Wang Y , Cen J , et al. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes[J]. Nat Cell Biol, 2019, 21 (8): 1015- 1026. |
| 43 | Skardal A , Shupe T , Atala A . Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling[J]. Drug Discov Today, 2016, 21 (9): 1399- 1411. |
| 44 | Uchino S , Kellum JA , Bellomo R , et al. Acute renal failure in critically ill patients: a multinational, multicenter study[J]. JAMA, 2005, 294 (7): 813- 818. |
| 45 | Morizane R , Lam AQ , Freedman BS , et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury[J]. Nat Biotechnol, 2015, 33 (11): 1193- 1200. |
| 46 | Eder A , Vollert I , Hansen A , et al. Human engineered heart tissue as a model system for drug testing[J]. Adv Drug Deliv Rev, 2016, 96, 214- 224. |
| 47 | Voges HK , Mills RJ , Elliott DA , et al. Development of a human cardiac organoid injury model reveals innate regenerative potential[J]. Deve-lopment, 2017, 144 (6): 1118- 1127. |
| 48 | Lancaster MA , Renner M , Martin CA , et al. Cerebral organoids model human brain development and microcephaly[J]. Nature, 2013, 501 (7467): 373- 379. |
| 49 | Gjorevski N , Sachs N , Manfrin A , et al. Designer matrices for intestinal stem cell and organoid culture[J]. Nature, 2016, 539 (7630): 560- 564. |
| 50 | Tuveson D , Clevers H . Cancer modeling meets human organoid technology[J]. Science, 2019, 364 (6444): 952- 955. |
/
| 〈 |
|
〉 |